Tous Actualités
Suivre
Abonner Dalton Pharma Services

Dalton Pharma Services

Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration With Boehringer Ingelheim (Canada) Ltd.

Toronto (ots/PRNewswire)

Dalton Medicinal Chemistry Partners,
the Medicinal Chemistry arm of Dalton Pharma Services, announces that
it has achieved a targeted milestone in its Medicinal Chemistry
agreement with Boehringer Ingelheim (Canada) Ltd. The milestone
achievement triggered payment of an undisclosed amount.
Dalton Medicinal Chemistry Partners is utilizing their medicinal
chemistry expertise to design and synthesize novel compounds against
an antiviral target selected by Boehringer Ingelheim (Canada) Ltd.
Peter Pekos, President of Dalton Pharma Services, said: "We are
pleased to achieve this milestone in our exciting partnership with
Boehringer Ingelheim (Canada) Ltd. It is a pleasure working with the
talented team at BI."
About Dalton
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a
Health Canada approved contract pharmaceutical manufacturer that
supplies chemistry and analytical services to the biotechnology and
pharmaceutical industries in the areas of chemistry, medicinal
chemistry and fine chemical manufacture. Dalton provides cGMP
manufacturing and sterile filling services to its customers at any
stage of the regulatory process (Phase I, II, III or commercial). In
its state of the art cGMP facilities, Dalton produces active
pharmaceutical ingredients (API) at the gram or kilogram scale.
Dalton carries out sterile fills to produce batches of finished drug
product in vials or syringes, either aseptically filled or terminally
sterilized, under fully validated conditions. In addition, Dalton's
analytical chemistry laboratory offers method development, validation
and ICH stability programs to its clients.

Contact:

For further information: Peter Pekos, President & CEO, Dalton Pharma
Services, 349 Wildcat Road, Toronto, Ontario, ppekos@dalton.com, Tel:
+1-416-661-2102, Fax: +1-416-661-2108